LAMP1 and Platelet storage pool disease: Although AntiOxCIN4 treatment of fibroblasts from sPD patients resulted in increased Lysotracker Red-labeled bodies and LAMP1 mRNA levels, meaning that lysosomal biogenesis is increased, it does not necessarily mean a more elevated autophagic capacity.